title: Reply by the authors.
authors.forename: Alin Adrian
authors.initials: AA
authors.lastname: Cumpanas
authors.forename: Mircea
authors.initials: M
authors.lastname: Botoca
authors.forename: Radu
authors.initials: R
authors.lastname: Minciu
authors.forename: Viorel
authors.initials: V
authors.lastname: Bucuras
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011467:Prostate / Q000000981:diagnostic imaging*; D011470:Prostatic Hyperplasia / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D014463:Ultrasonography
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D013449:Sulfonamides